GE HEALTHCARE TECHNOLOGIES INC. Revenue
GE HEALTHCARE TECHNOLOGIES INC. (GEHC) reported Revenue of $5.13 billion for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-04-29
- GE HEALTHCARE TECHNOLOGIES INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $5.13B, a 7.41% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $5.70B, a 7.13% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $5.14B, a 5.76% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-06-30 was $5.01B, a 3.47% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $20.63B, a 4.84% increase from fiscal 2024.
- GE HEALTHCARE TECHNOLOGIES INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $19.67B, a 0.61% increase from fiscal 2023.
- GE HEALTHCARE TECHNOLOGIES INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $19.55B, a 6.60% increase from fiscal 2022.
- GE HEALTHCARE TECHNOLOGIES INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $18.34B, a 4.30% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-03-31 | $5.13B 10-Q · filed 2026-04-29 | $10.83B derived: sum of 2 quarters · filed 2026-04-29 | $15.97B derived: sum of 3 quarters · filed 2026-04-29 | $20.98B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $5.70B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $10.84B derived: sum of 2 quarters · filed 2026-02-04 | $15.85B derived: sum of 3 quarters · filed 2026-02-04 | $20.63B 10-K · filed 2026-02-04 |
| 2025-09-30 | $5.14B 10-Q · filed 2025-10-29 | $10.15B derived: sum of 2 quarters · filed 2025-10-29 | $14.93B 10-Q · filed 2025-10-29 | $20.25B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $5.01B 10-Q · filed 2025-07-30 | $9.78B 10-Q · filed 2025-07-30 | $15.10B derived: sum of 3 quarters · filed 2026-04-29 | $19.97B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $4.78B 10-Q · filed 2026-04-29 | $10.10B derived: sum of 2 quarters · filed 2026-04-29 | $14.96B derived: sum of 3 quarters · filed 2026-04-29 | $19.80B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $5.32B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $10.18B derived: sum of 2 quarters · filed 2026-02-04 | $15.02B derived: sum of 3 quarters · filed 2026-02-04 | $19.67B 10-K · filed 2026-02-04 |
| 2024-09-30 | $4.86B 10-Q · filed 2025-10-29 | $9.70B derived: sum of 2 quarters · filed 2025-10-29 | $14.35B 10-Q · filed 2025-10-29 | $19.56B derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-06-30 | $4.84B 10-Q · filed 2025-07-30 | $9.49B 10-Q · filed 2025-07-30 | $14.70B derived: sum of 3 quarters · filed 2026-02-04 | $19.52B derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-03-31 | $4.65B 10-Q · filed 2025-04-30 | $9.86B derived: sum of 2 quarters · filed 2026-02-04 | $14.68B derived: sum of 3 quarters · filed 2026-02-04 | $19.50B derived: sum of 4 quarters · filed 2026-02-04 |
| 2023-12-31 | $5.21B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $10.03B derived: sum of 2 quarters · filed 2026-02-04 | $14.85B derived: sum of 3 quarters · filed 2026-02-04 | $19.55B 10-K · filed 2026-02-04 |
| 2023-09-30 | $4.82B 10-Q · filed 2024-10-30 | $9.64B derived: sum of 2 quarters · filed 2024-10-30 | $14.35B 10-Q · filed 2024-10-30 | $19.28B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $4.82B 10-Q · filed 2024-07-31 | $9.52B 10-Q · filed 2024-07-31 | $14.46B derived: sum of 3 quarters · filed 2025-02-13 | $19.04B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $4.71B 10-Q · filed 2024-04-30 | $9.64B derived: sum of 2 quarters · filed 2025-02-13 | $14.22B derived: sum of 3 quarters · filed 2025-02-13 | $18.70B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $4.94B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $9.51B derived: sum of 2 quarters · filed 2025-02-13 | $14.00B derived: sum of 3 quarters · filed 2025-02-13 | $18.34B 10-K · filed 2025-02-13 |
| 2022-09-30 | $4.58B 10-Q · filed 2023-10-31 | $9.06B derived: sum of 2 quarters · filed 2023-10-31 | $13.40B 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $4.48B 10-Q · filed 2023-07-25 | $8.83B 10-Q · filed 2023-07-25 | ||
| 2022-03-31 | $4.34B 10-Q · filed 2023-04-25 | |||
| 2021-12-31 | $17.59B 10-K · filed 2024-02-06 |